Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities


	Total number of shares purchased (1)	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Approximate dollar value of shares that may yet be purchased under the plans or programs ($000’s omitted) (2)
January 1, 2026 to January 31, 2026	751,759	$	126.37	751,759	$	887,902
February 1, 2026 to February 28, 2026	698,093	$	136.08	698,093	$	792,902
March 1, 2026 to March 31, 2026	969,280	$	121.93	969,280	$	674,719
Total	2,419,132	$	127.39	2,419,132

(1) During 2026, participants surrendered shares for payment of minimum tax obligations upon the vesting or exercise of previously granted share-based compensation awards. Such shares were not repurchased as part of our publicly-announced share repurchase programs and are excluded from the table above.

(2) On January 29, 2025, the Board of Directors approved an increase to our share repurchase authorization of $1.5 billion, which was publicly announced on January 30, 2025. There is no expiration date for this program, under which $674.7 million remained available for repurchases as of March 31, 2026. On April 22, 2026, the Board of Directors approved an additional increase to our share repurchase authorization of $1.5 billion, which was publicly announced on April 23, 2026. There is also no expiration date for this program.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information